Should you buy Faeth Therapeutics (FTH)?
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Engine methodology range
Range computation requires sufficient peer-comparable data; available for tickers with peer_count ≥3.
What the engine is tracking
- Large Analyst Upside Favorable Asymmetry—
- Quality Below Floor Cash Burn—
- Extreme High Short Interest—
- +1 more pillar — see the Why tab for full reasoning
→ Full pillar scorecard with all 4 pillars + per-dimension breakdown
When this thesis breaks
Falsifiable conditions per pillar — any one trip warrants review independent of price action. Engine-derived; not personalized advice.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Quality Below Floor Cash Burn
Trip ifFree cash flow turns positive, or the Piotroski F-Score rises above 4 out of 9 from the current 2, showing the quality floor breach has resolved.
- P2Extreme High Short Interest
Trip ifShort interest falls below 50% of float from the current 85%, showing the bearish positioning has unwound.
- P3Large Analyst Upside Favorable Asymmetry
Trip ifAnalyst upside falls below 40% from the current 138%, or the asymmetry ratio drops below 2.0 from the current 7.12, showing the favorable risk/reward has deteriorated.
- P4Overbought Momentum With DistributionTripped
Trip ifPrice rises more than 10% over the next 3 months while RSI stays above 70, showing the overbought warning failed to predict a pullback.
How the engine reached this verdict
TrendMatrix's engine output for Faeth Therapeutics, Inc. (FTH) is SELL_IF_HOLDING with medium conviction, score 5.7/10 at $33.33. Multiple gates have flipped against the verdict; the engine output is SELL.
The engine's exit framework anchors to a tactical sell band near $33.33, with structural invalidation at $31.02. The asymmetric R:R against a reversal hypothesis is 2.81 — the upside scenario exists, but it requires multiple structural gates to flip; the downside scenario requires only one more disappointment. The engine's sizing output: 0.5% of portfolio at this asymmetry level (none-conviction tier).
On the bear side: Concentration risk — Pipeline: PIKTOR; Quality below floor (1.5 < 4.0). Active engine warnings: Quality below floor (1.5 < 4.0).
SELL output reflects multiple gate failures; recovery requires a confluence of those gates re-clearing, not a single dimension move.
For the full 10-dimension breakdown + V9 gate detail: Why TrendMatrix rates FTH — 10-dimension breakdown →
Bear case
- ▸Concentration risk — Pipeline: PIKTOR
- ▸Quality below floor (1.5 < 4.0)